Is 0RB3 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
4/6
Valuation Score 4/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 0RB3 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 0RB3 (DKK141.5) is trading below our estimate of fair value (DKK818.89)
Significantly Below Fair Value: 0RB3 is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 0RB3?
Key metric: As 0RB3 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
The above table shows the Price to Earnings ratio for 0RB3. This is calculated by dividing 0RB3's market cap by their current
earnings.
What is 0RB3's PE Ratio?
PE Ratio
7.8x
Earnings
DKK 980.00m
Market Cap
DKK 7.65b
0RB3 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Price-To-Earnings vs Industry: 0RB3 is expensive based on its Price-To-Earnings Ratio (7.8x) compared to the European Shipping industry average (7.7x).
Price to Earnings Ratio vs Fair Ratio
What is 0RB3's PE Ratio
compared to its
Fair PE Ratio?
This is the expected PE Ratio taking into
account the company's forecast earnings growth, profit margins
and other risk factors.
0RB3 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio
7.8x
Fair PE Ratio
17x
Price-To-Earnings vs Fair Ratio: 0RB3 is good value based on its Price-To-Earnings Ratio (7.8x) compared to the estimated Fair Price-To-Earnings Ratio (17x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
The above table shows the analyst 0RB3 forecast and predictions for the stock price in 12 month’s time.
Date
Share Price
Average 1Y Price Target
Dispersion
High
Low
1Y Actual price
Analysts
Current
DKK 141.50
DKK 347.50
+145.6%
7.9%
DKK 375.00
DKK 320.00
n/a
2
Nov ’25
DKK 148.60
DKK 347.50
+133.8%
7.9%
DKK 375.00
DKK 320.00
n/a
2
Oct ’25
DKK 168.99
DKK 347.50
+105.6%
7.9%
DKK 375.00
DKK 320.00
n/a
2
Sep ’25
DKK 184.36
DKK 342.50
+85.8%
6.6%
DKK 365.00
DKK 320.00
n/a
2
Aug ’25
DKK 187.95
DKK 324.00
+72.4%
17.9%
DKK 402.00
DKK 239.00
n/a
4
Jul ’25
DKK 204.13
DKK 348.00
+70.5%
12.5%
DKK 402.00
DKK 285.00
n/a
4
Jun ’25
DKK 213.05
DKK 348.00
+63.3%
12.5%
DKK 402.00
DKK 285.00
n/a
4
May ’25
DKK 213.00
DKK 349.25
+64.0%
13.0%
DKK 402.00
DKK 285.00
n/a
4
Apr ’25
DKK 199.02
DKK 349.25
+75.5%
13.0%
DKK 402.00
DKK 285.00
n/a
4
Mar ’25
DKK 207.94
DKK 349.25
+68.0%
13.0%
DKK 402.00
DKK 285.00
n/a
4
Feb ’25
DKK 236.03
DKK 374.00
+58.5%
14.7%
DKK 451.00
DKK 315.00
n/a
4
Jan ’25
DKK 223.03
DKK 364.50
+63.4%
14.6%
DKK 433.00
DKK 310.00
n/a
4
Dec ’24
DKK 212.80
DKK 359.50
+68.9%
16.4%
DKK 433.00
DKK 290.00
n/a
4
Nov ’24
DKK 203.81
DKK 385.00
+88.9%
14.3%
DKK 450.00
DKK 300.00
DKK 148.60
4
Oct ’24
DKK 233.19
DKK 396.25
+69.9%
9.7%
DKK 450.00
DKK 345.00
DKK 168.99
4
Sep ’24
DKK 228.01
DKK 396.25
+73.8%
9.7%
DKK 450.00
DKK 345.00
DKK 184.36
4
Aug ’24
DKK 243.79
DKK 385.00
+57.9%
8.3%
DKK 430.00
DKK 350.00
DKK 187.95
4
Jul ’24
DKK 248.87
DKK 385.00
+54.7%
8.3%
DKK 430.00
DKK 350.00
DKK 204.13
4
Jun ’24
DKK 258.46
DKK 393.33
+52.2%
8.4%
DKK 430.00
DKK 350.00
DKK 213.05
3
May ’24
DKK 271.88
DKK 393.33
+44.7%
8.4%
DKK 430.00
DKK 350.00
DKK 213.00
3
Apr ’24
DKK 277.38
DKK 393.33
+41.8%
8.4%
DKK 430.00
DKK 350.00
DKK 199.02
3
Mar ’24
DKK 286.80
DKK 393.33
+37.1%
8.4%
DKK 430.00
DKK 350.00
DKK 207.94
3
Feb ’24
DKK 262.52
DKK 391.67
+49.2%
8.9%
DKK 435.00
DKK 350.00
DKK 236.03
3
Jan ’24
DKK 260.30
DKK 396.67
+52.4%
7.3%
DKK 435.00
DKK 365.00
DKK 223.03
3
Dec ’23
DKK 255.40
DKK 396.67
+55.3%
7.3%
DKK 435.00
DKK 365.00
DKK 212.80
3
Nov ’23
DKK 230.98
DKK 408.33
+76.8%
9.6%
DKK 460.00
DKK 365.00
DKK 203.81
3
Analyst Forecast: Target price is more than 20% higher than the current share price, but there are not enough analysts covering the stock to determine statistical confidence in agreement.